Structures by: Sieroń L.
Total: 60
{7,16-bis[2-(prop-2-yn-1-yloxy)benzoyl]-5,14-dihydrodibenzo[b,i][1,4,8,11]tetraazacyclotetradecinato(2-)k^4^N} zinc(II)
C40H32N4O5SZn,3(C2H6OS)
Organic Chemistry Frontiers (2018) 5, 2 171
a=11.2639(12)Å b=15.6341(17)Å c=13.7495(15)Å
α=90° β=110.204(2)° γ=90°
7,16-[2,2'-(hexano-2,4-diyne-1,6-dioxy)-dibenzoylo]-5,14-dihydrodibenzo[b,i][1,4,8,11]tetraazacyclotetradecine
C38H26N4O4
Organic Chemistry Frontiers (2018) 5, 2 171
a=21.1618(16)Å b=11.9414(11)Å c=23.2097(17)Å
α=90° β=90° γ=90°
(R)-tert-butyl 4-((R)-2-(4-chlorophenyl)-5-oxo-2,5-dihydrofuran-2-yl)-2-oxopyrrolidine-1-carboxylate
C19H20ClNO5
Organic & biomolecular chemistry (2020) 18, 42 8633-8637
a=9.62610(9)Å b=6.61723(11)Å c=14.2237(2)Å
α=90° β=98.0027(11)° γ=90°
2-((6aS,7S,10aR)-2-methoxy-6-oxo-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-7-yl)acetaldehyde
C16H16O4
Organic & biomolecular chemistry (2019) 17, 17 4238-4242
a=7.92142(4)Å b=7.19257(4)Å c=11.36141(5)Å
α=90° β=97.7125(4)° γ=90°
2-((6aR,7R,10aS)-2-Methyl-6-oxo-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-7-yl)acetaldehyde
C16H16O3
Organic & biomolecular chemistry (2019) 17, 17 4238-4242
a=8.5399(1)Å b=7.2817(1)Å c=10.6201(1)Å
α=90° β=105.546(1)° γ=90°
C42H40N4O6Sn
C42H40N4O6Sn
New Journal of Chemistry (2020) 44, 15 5862-5872
a=34.4256(14)Å b=7.6022(3)Å c=14.6569(6)Å
α=90° β=99.167(6)° γ=90°
2-(2-hydroxynaphthylazo)benzoic acid
C17H12N2O3
New Journal of Chemistry (2020) 44, 15 5862-5872
a=16.5566(5)Å b=4.47010(10)Å c=19.8415(6)Å
α=90° β=111.270(7)° γ=90°
C50H58N4O8Sn2
C50H58N4O8Sn2
New Journal of Chemistry (2020) 44, 15 5862-5872
a=8.5110(3)Å b=14.2959(5)Å c=21.9517(8)Å
α=76.859(2)° β=83.682(2)° γ=73.089(2)°
C100H116N8O14Sn4,C7H8
C100H116N8O14Sn4,C7H8
New Journal of Chemistry (2020) 44, 15 5862-5872
a=12.1753(1)Å b=13.8987(1)Å c=15.6416(1)Å
α=103.640(1)° β=90.895(1)° γ=103.259(1)°
[8-(3'-(3,5-dibenzyloxy-benzyloxy)-2'-hydroxyphenyl)- (5,6)-benzo-4,7-diazaocta-2,7-dien-1-onato(2-)]nickel(II)
C44H36N2NiO5
New J. Chem. (2004) 28, 12 1615-1621
a=7.2878(5)Å b=14.4364(8)Å c=17.4246(10)Å
α=72.557(5)° β=85.278(5)° γ=82.046(5)°
[8-(3'-Ac-(D,L)-alanyloxy)-2'-hydroxyphenyl)-(5,6)-benzo -4,7-diazaocta-2,7-dien-1-onato(2-)]nickel(II)
C28H25N3NiO5
New J. Chem. (2004) 28, 12 1615-1621
a=23.2759(3)Å b=8.43810(10)Å c=25.9355(3)Å
α=90° β=96.4760(10)° γ=90°
[8-(3'-Boc-(L)-phenylalanyloxy-2'-hydroxyphenyl)-(5,6) -benzo-3-methyl-1-phenyl-4,7-diazaocta-2,7-dien-1 -onato(2-)]nickel(II) dihydrate
C37H35N3NiO6,2(H2O)
New J. Chem. (2004) 28, 12 1615-1621
a=21.8152(3)Å b=7.57810(10)Å c=22.9560(4)Å
α=90° β=114.2092(7)° γ=90°
2-benzoyloxy-5-methylbenzophenone
C21H16O3
Acta Crystallographica Section E (2004) 60, 10 o1889-o1891
a=9.2068(5)Å b=9.7961(5)Å c=10.1375(6)Å
α=94.732(4)° β=112.570(5)° γ=102.194(4)°
Quinolinum perchlorate
C9H8N,ClO4
Acta Crystallographica Section E (2005) 61, 7 o2091-o2092
a=5.4935(5)Å b=22.3315(10)Å c=7.9970(4)Å
α=90° β=99.401(6)° γ=90°
Catena-Poly[[aqua(diformato-κO)copper(II)]-μ-1,4-diazabicyclo[2.2.2]octane- κ^2^N:N]
C8H16CuN2O5
Acta Crystallographica Section E (2003) 59, 9 m803-m805
a=6.8084(13)Å b=12.071(2)Å c=6.4224(15)Å
α=90° β=90° γ=90°
Tetrakis(μ-acetato-κ^2^O:O)bis[(2-aminopyridine-κN)copper(II)]
C18H24Cu2N4O8
Acta Crystallographica Section E (2004) 60, 5 m577-m578
a=7.4498(3)Å b=19.6500(7)Å c=8.1251(4)Å
α=90° β=114.316(4)° γ=90°
Aqua(malonato-κ^2^O,O)(pyridine-2-carboxamide-κ^2^N^1^,O)copper(II) monohydrate
C9H10CuN2O6,H2O
Acta Crystallographica Section E (2004) 60, 3 m297-m299
a=8.0566(5)Å b=8.7694(7)Å c=10.4093(7)Å
α=68.540(7)° β=81.355(5)° γ=63.933(7)°
Pentacarbonyl(3,3,4,4'-tetramethyl-1,1'-diphosphaferrocene-κP)tungsten(0)
C17H16FeO5P2W
Acta Crystallographica Section E (2004) 60, 12 m1828-m1829
a=13.279(13)Å b=10.857(9)Å c=14.061(12)Å
α=90° β=101.02(7)° γ=90°
trans-Diperchlorato-bis(pyridine-2-carboxamide-N',O)copper(II)
C12H12Cl2CuN4O10
Acta Crystallographica Section C (1998) 54, 3 322-324
a=5.8839(11)Å b=9.104(2)Å c=9.205(2)Å
α=92.60(2)° β=101.697(15)° γ=107.608(14)°
Poly[bis(benzimidazole-N^3^)copper(II)-μ-aqua-μ- acetylenedicarboxylato-O:O]
[Cu(C4O4)(C7H6N2)2(H2O)]
Acta Crystallographica Section C (1998) 54, 10 1431-1435
a=12.1670(10)Å b=14.712(2)Å c=10.1800(10)Å
α=90° β=103.480(10)° γ=90°
Poly[bis(benzimidazole-N^3^)copper(II)-μ-aqua-μ-fumarato-O:O]
[Cu(C4H2O4)(C7H6N2)2(H2O)]
Acta Crystallographica Section C (1998) 54, 10 1431-1435
a=12.941(2)Å b=13.292(2)Å c=10.398(2)Å
α=90° β=100.090(10)° γ=90°
Diaqua-bis(pyridine-2-carboxamide-N',O)copper(II) Dichloride
C12H16Cl2CuN4O4
Acta Crystallographica Section C (1997) 53, 3 296-298
a=6.2976(7)Å b=10.0596(14)Å c=12.8122(11)Å
α=90° β=93.316(8)° γ=90°
Diaqua-bis(pyridine-2-carboxamide-N',O)copper(II) Dibromide
C12H16Br2CuN4O4
Acta Crystallographica Section C (1997) 53, 3 296-298
a=6.3722(6)Å b=10.2962(8)Å c=13.1279(14)Å
α=90° β=94.400(8)° γ=90°
cis-Bis(2-aminobenzothiazole-N)-bis(formato-O,O')copper(II)
C16H14CuN4O4S2
Acta Crystallographica Section C (1999) 55, 2 167-169
a=18.3481(16)Å b=8.3075(7)Å c=13.2995(9)Å
α=90° β=113.960(6)° γ=90°
Catena-Poly[diaqua(pyridine-2-carboxamide-N^1^,O)-copper(II)-μ-sulfato-O,O] monohydrate
C6H12CuN2O8S
Acta Crystallographica Section C (1999) 55, 4 491-494
a=6.9446(6)Å b=9.8415(7)Å c=17.0921(13)Å
α=94.102(6)° β=94.906(6)° γ=100.050(6)°
Catena-Poly[bis(benzimidazole-N^3^)copper(II)-μ-sebacato-O,O:O'',O'''] Dihydrate
[Cu(C10H16O4)(C7H6N2)2],2H2O
Acta Crystallographica Section C (1999) 55, 8 1230-1234
a=6.850(4)Å b=9.071(3)Å c=11.208(4)Å
α=74.68(3)° β=74.46(3)° γ=71.13(3)°
1,2,4-triazolium bromide
C2H4N3,Br
Acta Crystallographica Section E (2007) 63, 2 o904-o905
a=4.9158(3)Å b=10.3166(6)Å c=9.8656(6)Å
α=90° β=102.411(7)° γ=90°
Catena-Poly[[bis(2-amino-1,3-benzothiazole-κN^3^)copper(II)]-μ- adipato-κ^4^O,O:O'',O''']
C20H20CuN4O4S2
Acta Crystallographica Section E (2007) 63, 2 m598-m600
a=8.6406(2)Å b=9.3336(2)Å c=13.3911(3)Å
α=90° β=102.719(2)° γ=90°
Aquabis(chloroacetato-κ<i>O</i>)bis(pyridine-κN)copper(II)
C14H16Cl2CuN2O5
Acta Crystallographica Section E (2007) 63, 6 m1659-m1661
a=16.3650(6)Å b=5.8030(2)Å c=18.3458(6)Å
α=90° β=90.511(3)° γ=90°
Tetrakis(μ-chloroacetato-κ^2^<i>O</i>:<i>O</i>)bis[(<i>N</i>,<i>N</i>-\ dimethylformamide-κ<i>O</i>)copper(II)]
C14H22Cl4Cu2N2O10
Acta Crystallographica Section E (2007) 63, 7 m1966-m1966
a=7.9969(6)Å b=8.0326(5)Å c=10.2420(7)Å
α=87.824(5)° β=71.974(6)° γ=80.015(6)°
Bis(2-amino-2-thiazolinium) dichromate(VI)
2(C3H7N2S),Cr2O72
Acta Crystallographica Section E (2007) 63, 8 m2068-m2068
a=8.03040(10)Å b=6.53320(10)Å c=14.1019(2)Å
α=90° β=95.065(2)° γ=90°
Aqua(oxydiacetato-κ^3^<i>O</i>,<i>O</i>,<i>O</i>'')(pyridine-2-carboxamide- κ^2^<i>N</i>^1^,<i>O</i>)copper(II)
C10H12CuN2O7
Acta Crystallographica Section E (2007) 63, 12 m3087-m3087
a=7.73550(10)Å b=13.2772(2)Å c=12.4147(2)Å
α=90° β=104.333(2)° γ=90°
Bis(2-aminopyrimidin-1-ium) dichromate(VI)
2(C4H6N3),Cr2O72
Acta Crystallographica Section E (2007) 63, 9 m2336-m2336
a=5.4576(2)Å b=7.6077(2)Å c=18.6840(10)Å
α=99.4290(10)° β=91.2770(10)° γ=108.319(2)°
1<i>H</i>-Benzotriazol-3-ium (1<i>H</i>-benzotriazole-κ<i>N</i>^3^)trichloridocobalt(II) monohydrate
C6H6N3,C6H5Cl3CoN3,H2O
Acta Crystallographica Section E (2008) 64, 1 m58-m58
a=6.8760(8)Å b=7.8033(12)Å c=16.657(3)Å
α=95.450(13)° β=95.962(8)° γ=103.989(9)°
Tetrakis(1H-benzimidazole-κN^3^)(sulfato-κO)copper(II) dimethyl sulfoxide solvate
C28H24CuN8O4S,C2H6OS
Acta Crystallographica Section E (2007) 63, 2 m579-m580
a=10.347(2)Å b=10.744(2)Å c=15.121(3)Å
α=98.99(3)° β=109.88(3)° γ=91.45(3)°
Pyridazinium perchlorate
C4H5N2,ClO4
Acta Crystallographica Section E (2007) 63, 3 o1199-o1200
a=5.27604(10)Å b=8.62700(16)Å c=15.0058(3)Å
α=90° β=94.8879(19)° γ=90°
Trans-Bis(hydrogen maleato-κO)bis(pyridine-2-carboxamide-κ^2^N^1^,O)copper(II)
C20H18CuN4O10
Acta Crystallographica Section E (2007) 63, 3 m862-m864
a=11.0611(10)Å b=12.6061(9)Å c=7.8818(6)Å
α=90° β=91.190(8)° γ=90°
N-Boc-α-isobutyl-D-serine-β-lactone
C12H21NO4
Acta Crystallographica Section E (2008) 64, 1 o207-o207
a=6.1642(7)Å b=11.2018(16)Å c=11.6915(14)Å
α=115.936(14)° β=100.621(10)° γ=95.362(11)°
Poly[bis(μ~2~-formato-κ^2^O:O)(quinoxaline-κN)copper(II)]
C10H8CuN2O4
Acta Crystallographica Section E (2008) 64, 1 m53-m53
a=9.5648(3)Å b=11.1913(3)Å c=10.1910(4)Å
α=90° β=108.284(3)° γ=90°
Benzotriazolium perchlorate monohydrate
C6H6N3,ClO4,H2O
Acta Crystallographica Section E (2007) 63, 5 o2089-o2090
a=7.4227(2)Å b=8.0524(2)Å c=8.8973(3)Å
α=74.023(3)° β=74.335(3)° γ=87.246(2)°
Phenazinium perchlorate
C12H9N2,ClO4
Acta Crystallographica Section E (2007) 63, 5 o2508-o2508
a=7.2025(5)Å b=7.8494(4)Å c=11.1564(8)Å
α=81.463(5)° β=80.539(6)° γ=74.005(5)°
Benzimidazolium perchlorate
C7H7N2,ClO4
Acta Crystallographica Section E (2007) 63, 8 o3585-o3585
a=9.9885(2)Å b=9.05090(10)Å c=19.0182(3)Å
α=90° β=90° γ=90°
N-Boc-α-isopropyl-D-serine-β-lactone
C11H19NO4
Acta Crystallographica Section E (2008) 64, 3 o550
a=6.0475(2)Å b=20.8957(6)Å c=10.2928(3)Å
α=90° β=94.675(3)° γ=90°
Bis(2-amino-2-thiazolinium) tetra-μ-formato-κ^8^O:O)bis[(formato-κO)copper(II)]
2(C3H7N2S),C6H6Cu2O122
Acta Crystallographica Section C (2007) 63, 5 m199-m200
a=6.5347(5)Å b=7.5170(8)Å c=12.4428(5)Å
α=80.022(6)° β=80.203(5)° γ=67.250(8)°
Captopril
C9H15NO3S
Acta Crystallographica Section C (2015) 71, 3
a=6.80010(10)Å b=8.8015(2)Å c=17.4805(3)Å
α=90° β=90° γ=90°
Captopril disulfide
C18H28N2O6S2
Acta Crystallographica Section C (2015) 71, 3
a=6.6678(4)Å b=11.0680(6)Å c=14.4219(8)Å
α=90° β=91.925(2)° γ=90°
Trityl losartan
C41H37ClN6O
Acta Crystallographica Section C (2004) 60, 11 o821-o823
a=8.6962(3)Å b=20.5493(6)Å c=21.7392(5)Å
α=69.597(2)° β=88.587(2)° γ=78.962(3)°
(1<i>S</i>)-2-((<i>S</i>)-{1-[(2<i>S</i>,3a<i>S</i>,7a<i>S</i>)-2- carboxyoctahydro-1<i>H</i>-indol-1-yl]-1-oxopropan-2-yl}azaniumyl)pentanoate dimethyl sulfoxide hemisolvate
C17H28N2O5,0.5(C2H6OS)
Acta Crystallographica Section C (2012) 68, 9 o341-o343
a=10.3504(7)Å b=16.0908(11)Å c=24.4828(16)Å
α=90° β=90° γ=90°
(1<i>S</i>)-2-((<i>S</i>)-{1-[2<i>S</i>,3a<i>S</i>,7a<i>S</i>)-2- carboxyoctahydro-1<i>H</i>-indol-1-yl]-1-oxopropan-2yl}azaniumyl)pentanoate monohydrate
C17H28N2O5,H2O
Acta Crystallographica Section C (2012) 68, 11 o443-o446
a=8.1645(2)Å b=10.0136(2)Å c=23.2429(5)Å
α=90° β=90° γ=90°
Diphenyl [3-methyl-1-(3-phenylthioureido)butyl]phosphonate
C24H27N2O3PS
Acta Crystallographica Section C (2003) 59, 1 o46-o50
a=10.1931(7)Å b=10.5503(5)Å c=11.9560(7)Å
α=90.932(4)° β=103.252(5)° γ=101.923(5)°
Diphenyl [2-methyl-1-(3-phenylthioureido)butyl]phosphonate
C24H27N2O3PS
Acta Crystallographica Section C (2003) 59, 1 o46-o50
a=9.9402(4)Å b=16.7505(6)Å c=14.1979(5)Å
α=90° β=91.973(3)° γ=90°
Ethyl (2<i>S</i>)-2-[(3<i>S</i>,5a<i>S</i>,9a<i>S</i>,10a<i>S</i>)-3-methyl-1,4-dioxo-5a,6,7,8,9,9a,10,10a-octahydro-3<i>H</i>-pyrazino[1,2-<i>a</i>]indol-2-yl]pentanoate
C19H30N2O4
Acta Crystallographica Section C (2013) 69, 6 630-633
a=9.2089(10)Å b=17.9875(17)Å c=23.697(2)Å
α=90° β=90° γ=90°
Ethyl (2<i>S</i>)-2-[(3<i>S</i>,5a<i>S</i>,9a<i>S</i>,10a<i>S</i>)-3-methyl-1,4-dioxo-5a,6,7,8,9,9a,10,10a-octahydro-3<i>H</i>-pyrazino[1,2-<i>a</i>]indol-2-yl]pentanoate
C19H30N2O4
Acta Crystallographica Section C (2013) 69, 6 630-633
a=9.2606(8)Å b=9.2606(8)Å c=44.847(4)Å
α=90° β=90° γ=90°
Olanzapine acetic acid monosolvate
C17H20N4S,C2H4O2
Acta Crystallographica Section C (2013) 69, 7 781-786
a=10.14740(10)Å b=12.85620(10)Å c=14.54940(10)Å
α=90° β=92.92° γ=90°
Olanzapine propan-2-ol hemisolvate monohydrate
C17H20N4S,0.5(C3H8O),H2O
Acta Crystallographica Section C (2013) 69, 7 781-786
a=24.5414(4)Å b=12.5088(3)Å c=15.3096(4)Å
α=90° β=125.3140(10)° γ=90°
Olanzapine propan-2-one hemisolvate monohydrate
C17H20N4S,0.5(C3H6O),H2O
Acta Crystallographica Section C (2013) 69, 7 781-786
a=24.5759(14)Å b=12.5608(5)Å c=15.1607(9)Å
α=90° β=125.790(9)° γ=90°
Bis[bis(2-amino-1,3-benzothiazole-N^3^)(μ-succinato-O,O,O'',O''')copper(II)]
C36H32Cu2N8O8S4
Acta Crystallographica Section C (2000) 56, 1 19-21
a=9.239(2)Å b=15.643(3)Å c=13.859(3)Å
α=90° β=102.37(2)° γ=90°
Bis[N-(4,4-diphenyl-5-oxo-4,5-dihydro-1H-imidazol-2- yl)glycinato]copper(II) dimethylformamide disolvate
C34H28CuN6O6,2C3H7NO
Acta Crystallographica Section C (2008) 64, 2 m79-m82
a=8.987(4)Å b=14.075(6)Å c=16.208(7)Å
α=90° β=95.913(6)° γ=90°
Aquabis[N-(4,4-diphenyl-5-oxo-4,5-dihydro-1H-imidazol-2- yl)glycinato]copper(II) dimethylformamide disolvate
C34H30CuN6O7,2C3H7NO
Acta Crystallographica Section C (2008) 64, 2 m79-m82
a=8.7305(3)Å b=30.0213(5)Å c=9.0447(2)Å
α=90° β=118.102(4)° γ=90°
Catena-Poly[bis(benzimidazole-N^3^)copper(II)-μ-suberato-O,O:O'',O''']
[Cu(C8H12O4)(C7H6N2)2]
Acta Crystallographica Section C (1999) 55, 8 1230-1234
a=7.3380(10)Å b=8.6269(5)Å c=8.8770(10)Å
α=80.980(10)° β=84.620(10)° γ=72.650(10)°